iMedix Medical Content Engine 3.13.37
Home/Drugs/Sporanox

Sporanox: Uses, dosage, side effects, warnings & patient reviews

Sporanox

Sporanox
sporanox capsule
1 / 3

Sporanox

Itraconazole
Sporanox is a prescription antifungal medication containing the active ingredient itraconazole. It is used to treat fungal infections, including onychomycosis (fungal nail infection) and various systemic fungal infections that affect internal organs.
  • ActiveIngredient: Itraconazole
  • DosageForm: Oral capsules, oral solution.
  • Dosage: Capsules: 100 mg. Oral Solution: 10 mg/mL (100 mg per 10 mL).
  • Indications: Blastomycosis (pulmonary and extrapulmonary); Histoplasmosis (including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis); Aspergillosis (pulmonary and extrapulmonary in patients who are intolerant of or refractory to amphotericin B therapy); Onychomycosis (fingernail and toenail) due to dermatophytes.
  • Manufacturer: Janssen Pharmaceuticals, Inc. (Brand); generic manufacturers include Torrent Pharmaceuticals, Citron Pharma, and Teva Pharmaceuticals.
  • Storage: Store at controlled room temperature 15°C–25°C (59°F–77°F); protect from light and moisture.
  • Drug Status: Prescription Only
Description

What is Sporanox (Itraconazole)?

Sporanox is an oral antifungal medication from the triazole class. It is indicated for the treatment of various fungal infections. It belongs to the broader category of antifungal drugs.

Its mechanism of action involves inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane. This disrupts membrane function, ultimately inhibiting fungal growth.

A key characteristic of itraconazole is its pharmacokinetic profile. It is highly lipophilic, meaning it distributes well into fatty tissues, skin, and nails. This property allows drug levels to persist at the site of infection, such as the toenail, for weeks after treatment is completed. The absorption of the capsule formulation is significantly enhanced when taken with a full meal.

General Instructions

How to Take Sporanox

Precise adherence to administration instructions is critical for the effectiveness and safety of Sporanox.

Administration and Timing

Sporanox capsules must be taken with a full meal to ensure adequate absorption. This is because the medication requires an acidic gastric environment for optimal dissolution and bioavailability.

Sporanox oral solution should be taken on an empty stomach. The bioavailability of the solution differs from that of the capsules, and the two formulations are not interchangeable.

Course Completion and Monitoring

It is essential to complete the entire prescribed course of therapy, even if symptoms appear to improve earlier. Stopping treatment prematurely can lead to relapse of the infection.

For treatments expected to last longer than one month, or in patients with pre-existing liver conditions, periodic monitoring of liver function tests is typically recommended by a healthcare provider.

Missed Dose

If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Doubling the dose to make up for a missed one is not recommended.

Side Effects

Side Effects of Sporanox

Common and Serious Side Effects of Sporanox (Itraconazole)
FrequencySide EffectsAction to Take
Common
  • Nausea, abdominal pain, or indigestion
  • Headache
  • Dizziness
  • Fatigue
  • Skin rash
These effects are often manageable. Taking capsules with food can reduce gastrointestinal upset. Report persistent symptoms to your doctor.
Serious (Seek Medical Help)
  • Signs of heart failure: shortness of breath, swelling in ankles/feet, unusual tiredness, rapid weight gain.
  • Signs of liver problems: persistent nausea/vomiting, loss of appetite, dark urine, yellowing of skin or eyes (jaundice), severe fatigue.
  • Signs of neuropathy: numbness, tingling, or pain in the hands or feet. For more information, see peripheral neuropathy.
  • Hearing loss.
  • Severe skin reactions.
Stop taking Sporanox and contact your healthcare provider immediately. These symptoms require prompt medical evaluation.
Uses

What is Sporanox Used For?

Sporanox is prescribed for specific fungal infections. A key challenge is correctly diagnosing the condition, as some nail disorders, like psoriatic nail dystrophy, can mimic fungal infection.

Primary Medical Uses

  • Onychomycosis: Treatment of fungal infections of the toenail or fingernail.
  • Systemic Fungal Infections: These include, but are not limited to, blastomycosis, histoplasmosis, and aspergillosis in non-immunocompromised patients.
  • Esophageal Candidiasis: Treatment of oral and esophageal thrush that has not responded to fluconazole treatment.
Safety advice

Interactions Alcohol:

Unsafe
Consumption of alcohol is not advised during treatment with Sporanox. Both substances are metabolized by the liver, and concurrent use increases the risk of hepatotoxicity. This risk is particularly elevated in individuals with a history of chronic alcohol use.

Interactions Other Medications:

Consult your doctor
Sporanox has numerous, potentially severe drug interactions due to its strong inhibition of the CYP3A4 liver enzyme. It is contraindicated with many medications, including certain statins, heart rhythm drugs, and migraine medications. A comprehensive review of all your medications with a doctor is essential. For example, it can dangerously increase levels of certain statin drugs.

Special Groups Pregnancy:

Unsafe
Itraconazole is contraindicated during pregnancy. Animal studies have shown evidence of fetal harm. For general guidance on medication use during pregnancy, refer to medication safety in pregnancy.

Special Groups Breastfeeding:

Unsafe
Itraconazole is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants, the use of Sporanox is not recommended while breastfeeding.

Special Groups Elderly:

Use with caution
Elderly patients may have a higher incidence of cardiac disorders and may be more susceptible to drug-induced side effects. The potential for drug interactions is also increased. Careful monitoring is required.

Special Groups Children:

Consult your doctor
The safety and effectiveness of Sporanox capsules in pediatric patients have not been established. The oral solution may be used in children over the age of 5 for specific systemic fungal infections, under strict medical supervision.

Effects on Activities Driving:

Use with caution
Sporanox may cause dizziness, vertigo, or fatigue. Patients should not drive or operate vehicles until they are certain the medication does not impair their alertness or coordination.

Effects on Activities Operating Machinery:

Use with caution
The same precautions as for driving apply. Activities requiring full mental alertness or physical coordination should be approached with caution until the individual's response to the drug is known.
Concerns

Important Safety Concerns and Considerations

Cardiac Risk: Congestive Heart Failure

Sporanox carries a Black Box Warning, the most serious FDA warning, regarding the risk of congestive heart failure (CHF). It is contraindicated for the treatment of onychomycosis in patients with evidence of ventricular dysfunction, such as CHF or a history of CHF. For other serious infections, the benefits and risks must be carefully weighed in patients with cardiac disease. If signs or symptoms of heart failure develop during treatment, discontinuation should be considered.

Hepatotoxicity

Serious hepatotoxicity, including liver failure and death, has occurred with itraconazole use. Liver function monitoring is recommended for patients receiving continuous therapy for more than one month, those with pre-existing liver disease, or those who develop symptoms suggestive of liver dysfunction. Symptoms can resemble autoimmune hepatitis.

Hearing Loss

Transient or permanent hearing loss has been reported. In some cases, hearing loss has recovered after treatment discontinuation, but in others, it has persisted. If hearing loss occurs, immediate discontinuation of Sporanox and an audiological evaluation are advised.

Reduced Absorption with Altered Gastric Acidity

The absorption of Sporanox capsules is highly dependent on gastric acidity. Drugs that reduce stomach acid (e.g., proton pump inhibitors, H2-receptor antagonists, antacids) can significantly decrease itraconazole absorption. Patients with achlorhydria or those taking such medications may require alternative therapy or monitoring.

Warnings

Critical Warnings for Sporanox Use

Drug Interaction Warnings

Sporanox has a second Black Box Warning regarding drug interactions. Co-administration with drugs that are primarily metabolized by the CYP3A4 enzyme and have the potential for serious adverse events is contraindicated. This list includes, but is not limited to:

  • Certain antiarrhythmics (e.g., disopyramide, dofetilide, quinidine).
  • The antipsychotic pimozide.
  • Ergot alkaloids (e.g., dihydroergotamine, ergotamine).
  • Triazolam and oral midazolam.
  • The antibiotic erythromycin.

Concurrent use can lead to elevated plasma levels of these drugs, resulting in serious or life-threatening cardiovascular events, including cardiac arrhythmias.

Interaction with Phosphodiesterase-5 (PDE5) Inhibitors

Sporanox significantly increases plasma concentrations of PDE5 inhibitors used for erectile dysfunction, such as sildenafil (Viagra), tadalafil, and vardenafil. If co-administration cannot be avoided, a substantial reduction in the dose of the PDE5 inhibitor is mandatory under close medical supervision.

Neuropathy

Peripheral neuropathy has been reported, primarily in patients receiving long-term therapy. If symptoms of neuropathy develop, the drug should be discontinued.

Hypersensitivity Reactions

Rare cases of severe hypersensitivity reactions, including anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported. Therapy should be discontinued if such reactions occur.

Dosage

Sporanox Dosage Information

Dosage is determined by the treating physician based on the type and severity of infection. The following are general guidelines; always follow your doctor’s specific prescription.

General Sporanox (Itraconazole) Dosage Guidelines
IndicationStandard Adult DosageTypical DurationNotes
Toenail Onychomycosis (with or without fingernail involvement)200 mg once daily.12 consecutive weeks.Pulse Therapy: An alternative regimen is 200 mg twice daily for 1 week, repeated after a 3-week drug-free interval. Two pulses for toenails, one pulse for fingernails.
Fingernail Onychomycosis200 mg twice daily.2 pulses (each pulse: 1 week of therapy, 3 weeks off).See “Pulse Therapy” note above.
Systemic Fungal Infections (e.g., blastomycosis, histoplasmosis)200 mg once or twice daily.Minimum of 3 months; until clinical parameters stabilize.Dosing is highly variable based on infection. Doses up to 400 mg/day may be used.
Esophageal Candidiasis100 mg to 200 mg daily.Minimum of 3 weeks; at least 2 weeks after symptoms resolve.Treatment should continue for a minimum of 2 weeks following resolution of symptoms.

Important Administration Notes

  • Formulation Differences: Capsules and oral solution are not bioequivalent and cannot be substituted on a milligram-per-milligram basis.
  • Renal Impairment: Itraconazole bioavailability may be reduced in patients with renal impairment. Monitoring of drug levels may be considered.
  • Hepatic Impairment: Use with caution. Itraconazole is extensively metabolized in the liver. Plasma concentrations should be monitored, and the dose adjusted if necessary.
Interactions

Drug Interactions with Sporanox

Due to its potent inhibition of the CYP3A4 enzyme, Sporanox interacts with a wide range of medications. This table lists some of the most significant interactions.

Significant Drug Interactions with Sporanox (Itraconazole)
Interacting Drug Class/ExampleEffect of InteractionRecommendation
HMG-CoA Reductase Inhibitors (Statins)
Simvastatin, Lovastatin, Atorvastatin		Markedly increases statin blood levels, raising the risk of severe muscle toxicity (rhabdomyolysis).Contraindicated with simvastatin and lovastatin. Use atorvastatin with caution at the lowest possible dose.
Benzodiazepines
Midazolam (oral), Triazolam		Greatly increases sedative effects and prolongs sedation.Contraindicated. Use other benzodiazepines with extreme caution.
Calcium Channel Blockers
Felodipine, Nifedipine		Increases levels of the calcium channel blocker, potentially causing edema and excessive lowering of blood pressure.Close monitoring of blood pressure and edema is required; dose reduction may be necessary.
Immunosuppressants
Cyclosporine, Tacrolimus, Sirolimus		Substantially increases levels of these drugs, raising the risk of nephrotoxicity and other serious side effects.Frequent monitoring of drug levels and renal function is mandatory. Dose reductions of 50% or more are often needed.
DigoxinIncreases digoxin levels, potentially leading to toxicity (nausea, vomiting, cardiac arrhythmias).Monitor digoxin serum concentrations closely and reduce the digoxin dose as needed.
Proton Pump Inhibitors / H2 Blockers
Omeprazole, Famotidine		Significantly reduces the absorption of itraconazole capsules, potentially leading to treatment failure.Avoid concurrent use. If acid suppression is necessary, consider using the oral solution (taken on an empty stomach).
FAQs
Itraconazole concentrates in the nail plate and persists there. While the medication is typically taken for 12 weeks, a new, healthy nail must grow out to replace the infected part. This process is slow; visible improvement at the base of the nail may be seen after several months, but full regrowth of a clear toenail can take 9 to 12 months.
The two formulations are not interchangeable. The capsule must be taken with food for proper absorption and is typically used for nail and systemic infections. The oral solution is taken on an empty stomach, has different bioavailability, and is often prescribed for oral/esophageal thrush. Your doctor will choose the appropriate formulation.
Yes. The most common oral alternative is terbinafine (Lamisil), which is often considered a first-line agent due to its efficacy and shorter continuous treatment duration. For certain yeast infections, fluconazole (Diflucan) may be used and generally has fewer drug interactions. The choice depends on the specific fungus, patient health, and drug interaction profile.
Itraconazole has a negative inotropic effect, meaning it can reduce the force of heart muscle contraction. This can be dangerous for individuals with pre-existing heart failure or ventricular dysfunction. A medical evaluation, which may include an echocardiogram, is often required before starting treatment for nail fungus to ensure it is safe.
No. Medications that reduce stomach acid, including antacids, H2-blockers (like famotidine), and proton pump inhibitors (like omeprazole), can drastically reduce the absorption of itraconazole from capsules, making the treatment ineffective. If you require acid-reducing therapy, discuss this with your doctor, as the oral solution may be an option.
Other Details

Additional Information

Obtaining Medication Safely

Sporanox is a prescription-only medication. It should only be obtained with a valid prescription from a licensed healthcare provider who has evaluated your condition and reviewed your full medical history and medication list.

Cost and Generic Availability

Itraconazole is available as a generic medication, which is typically less expensive than the brand-name Sporanox. Patients should discuss all options with their healthcare provider and pharmacist.

Reporting Side Effects

You are encouraged to report negative side effects of prescription drugs to the relevant national health authority (e.g., the FDA in the United States). Reporting helps health authorities monitor drug safety and identify new risks.

References

References and Medical Sources

The information on this page is compiled from reputable medical sources and prescribing information.

  1. U.S. Food and Drug Administration (FDA). Sporanox (itraconazole) Capsules Prescribing Information. [Updated 2014]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020083s062lbl.pdf
  2. MedlinePlus. Itraconazole. U.S. National Library of Medicine; [Updated 2021]. https://medlineplus.gov/druginfo/meds/a692049.html
  3. American Academy of Dermatology (AAD). Guidelines of care for the management of onychomycosis. Journal of the American Academy of Dermatology. 2014.
  4. Drugs.com. Itraconazole Professional Monograph. Drugs.com; [Updated 2024]. https://www.drugs.com/monograph/itraconazole.html
Disclaimer

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

You must login to add a comment.

Need An Account,

Popular Questions

Top Members

kovim
lapexa
pocase
Alex Gale

alternative-therapies autoimmune-disease boost-immune-system brain-health child-health diabetes-management diet-and-nutrition doctor-locations erectile-dysfunction exercise-and-fitness gut-health hair-health health-conditions healthcare-costs heart-health hormone-health medications-and-supplements mental-health pain-management pregnancy-health senior-health skin-health sleep-health womens-health

Join the discussion

Comments are published after moderation. User opinions do not constitute medical advice.

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.